HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

VMD

Viemed Healthcare, Inc. (NASDAQ)

Healthcare — Medical Devices

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

None 1 analysts
$11.92
(0.00%)
Target: $11.00 (-7.7%)
Sign in to add VMD to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$453.52M
P/E Ratio (TTM)31.97
Forward P/E29.57
EPS (TTM)$0.37
Dividend Yield-
Profit Margin5.20%
Revenue Growth27.50%
ROE10.89%
Debt/Equity8.53
Recommendation None
Analyst Target$11.00
Analysts1
Indexes NASDAQ

Technical Indicators

RSI (14)81.1
Beta1.13
SMA 20-
SMA 40-
52-Week High$11.90
52-Week Low$5.93
50-Day Avg$10.01
200-Day Avg$8.26
Avg Volume288.6K
Volume259.9K

Performance Analysis

NEUTRAL

VMD presents a mixed picture with both positive and negative indicators.

- Trading near its 52-week high ($11.90), which may indicate limited upside.
- RSI at 81.1 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
+ Strong revenue growth of 27.5% year-over-year.
~ Wall Street consensus is "none" from 1 analysts.
- Average analyst target of $11.00 implies 7.7% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:36 UTC

Back to Screener Export Report